Discovery Bioanalysis

In the dynamic landscape of drug discovery, identifying candidates with promising ADME (Absorption, Distribution, Metabolism, and Excretion) and pharmacokinetics properties is pivotal. These early-stage assessments lay the groundwork for future clinical trials and regulatory approvals.

However, the journey from discovery to successful outcomes demands more than just scientific insights. It requires reliable, qualified measurements at a clinical scale. That’s where Q² Solutions’ global bioanalytical services network excels.

Our expertise spans a wide range of areas, including:

• Bioanalysis for all non-regulated studies
• Biological fluids, tissue homogenates, dried blood spot (DBS) and other micro-sampling techniques
• Tiered offerings with varying level of rigor based on the program stage and needs
• Tecan liquid handlers for sample processing and Watson LIMS for data efficiency
• High throughput capacity and quick turnaround time
• Flexible offerings from fit for purpose to method qualification
• Plasma, serum, whole blood, urine, CSF and various tissue sample analysis for PK/PD, pharmacology, and non-regulated toxicology studies
• Analysis for drug and metabolite(s) as needed and cassette study sample analysis
• Flexible standard curve ranges with appropriate LLOQ as needed
• Non-compartmental PK analysis and SEND data files
• Non-regulated preclinical and clinical (exploratory purposes) sample analysis
• Method development and transfer for regulated bioanalysis